抗腦啡肽酶(CD10)單克隆抗體
Anti-Neprilysin (CD10) Monoclonal Antibody
NEP; MME; CALLA; SFE; Atriopeptidase; Enkephalinase; Skin fibroblast elastase; Common Acute Lymphoblastic Leukemia Antigen; Membrane Metallo-Endopeptidase
- 編號UFAB785Hu00
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 效價-
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種-
- 應(yīng)用FCM
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價格 ¥ 360 ¥ 600 ¥ 960 ¥ 1200 ¥ 2100
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Human peripheral blood lymphocytes were stained with 5μg/ml mouse Anti-human NEP Recombinant Antibody (Catalog FAB785Hu00, left) or Isotype control antibody (Catalog IS067-Mu03, right), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
用法
Flow cytometry: 5μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPB785Hu61 | 腦啡肽酶(CD10)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPB785Hu02 | 腦啡肽酶(CD10)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB785Hu01 | 腦啡肽酶(CD10)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPB785Hu61 | 腦啡肽酶(CD10)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB785Hu01 | 腦啡肽酶(CD10)多克隆抗體 | WB; IHC |
| UPAB785Hu02 | 腦啡肽酶(CD10)多克隆抗體 | WB; IHC |
| ULAB785Hu71 | 腦啡肽酶(CD10)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| UMAB785Hu21 | 腦啡肽酶(CD10)單克隆抗體 | WB; ICC/IF |
| UMAB785Hu23 | 腦啡肽酶(CD10)單克隆抗體 | WB |
| UMAB785Hu24 | 腦啡肽酶(CD10)單克隆抗體 | WB |
| UMAB785Hu22 | 腦啡肽酶(CD10)單克隆抗體 | WB |
| UMAB785Hu25 | 腦啡肽酶(CD10)單克隆抗體 | WB; IHC |
| UMAB785Hu27 | 腦啡肽酶(CD10)單克隆抗體 | WB |
| UMAB785Hu29 | 腦啡肽酶(CD10)單克隆抗體 | WB |
| UMAB785Hu28 | 腦啡肽酶(CD10)單克隆抗體 | WB; ICC/IF |
| UMAB785Hu26 | 腦啡肽酶(CD10)單克隆抗體 | WB |
| UFAB785Hu02 | 抗腦啡肽酶(CD10)單克隆抗體 | FCM |
| UFAB785Hu04 | 抗腦啡肽酶(CD10)單克隆抗體 | FCM |
| UFAB785Hu06 | 抗腦啡肽酶(CD10)單克隆抗體 | FCM |
| UFAB785Hu08 | 抗腦啡肽酶(CD10)單克隆抗體 | FCM |
| UFAB785Hu00 | 抗腦啡肽酶(CD10)單克隆抗體 | FCM |
| UFAB785Hu82 | 抗腦啡肽酶(CD10)單克隆抗體(異硫氰酸熒光素標記) | FCM |
| USEB785Hu | 腦啡肽酶(CD10)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB785Hu | 腦啡肽酶(CD10)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| 13 | Elevated Plasma levels of Neutral Endpeptidase in Hypertension Patients Treated with Angiotensin Converting Enzyme Inhibitors [Ahajournals:Source] |
| Biol Pharm Bull | Effect of High Glucose Levels on Amyloid β Production in Retinas of Spontaneous Diabetes Mellitus Otsuka Long-Evans Tokushima Fatty Rats [PubMed: 25832640] |
| Eur J Heart Fail.? | Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction [Pubmed:26725876] |
| 8 | A?Test?in?Context:?Neprilysin:?Function,?Inhibition, and?Biomarker. [pubmed:27491909] |
| European?Journal of?Heart?Failure | Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study [Pubmed: 30520545] |
| European?Journal of?Heart?Failure | Increased granulocyte membrane neprilysin (CD10) expression is associated with better prognosis in heart failure [Pubmed: 30828920] |
| Clinical Research in Cardiology | Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD) [Pubmed: 32002632] |
| Neurotoxicology | Involvement of hippocampal agmatine in β1-42 amyloid induced memory impairment, neuroinflammation and BDNF signaling disruption in mice [Pubmed: 32522471] |
| European Heart Journal | P1620 Association of granulocyte neprilysin (CD10) expression with prognosis in heart failure with reduced ejection fraction [] |
| Clin Biochem | Finding a reliable assay for soluble neprilysin [Pubmed:35331754] |
| Scientific Reports | The potential role of serum tau protein (MAPT), neuronal cell adhesion molecule (NrCAM) and neprilysin (NEP) in neurodegenerative disorders development in?… [] |
留言咨詢
